Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been ...
The U.S. Food and Drug Administration has issued a recall of glucose monitors used by those with diabetes for malfunctioning.
DexCom Inc. DXCM and Abbott Laboratories ABT are likely to launch their first over-the-counter (OTC) continuous glucose monitors (CGMs) in the coming months of 2024. Dexcom’s Stelo and Abbott’s Lingo ...
FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...
Abbott Laboratories (NYSE: ABT) and DexCom (NASDAQ: DXCM) turned in stellar performances in 2018. Abbott's shares jumped 27%, while DexCom stock more than doubled. It's a different story so far this ...
Two companies are making life a lot easier for people with diabetes. Abbott Laboratories (ABT 1.00%) and DexCom (DXCM 3.11%) market devices that allow for convenient monitoring of blood sugar levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results